BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, June 13, 2026
Home
»
Authors
» James Etheridge
James Etheridge
Articles
ARTICLES
Synt:em Raises EUR22M To Support Product Development
March 21, 2001
By
James Etheridge
Key Departure, Financials Send Genset's Stock Price Tumbling
March 14, 2001
By
James Etheridge
Key Departure, Financials Send Genset's Stock Price Tumbling
March 14, 2001
By
James Etheridge
DrugAbuse Reports Positive Phase II Results Of Naltrel
Feb. 21, 2001
By
James Etheridge
DrugAbuse Reports Positive Phase II Results Of Naltrel
Feb. 21, 2001
By
James Etheridge
Despite Resistance In France, Chirac Sees Place For GM Crops
Feb. 14, 2001
By
James Etheridge
Hybrigenics, Servier Collaborate On Discovery Of Cancer Drugs
Feb. 14, 2001
By
James Etheridge
Genset Cuts Back Genomics Focus, Moves On To Discovery
Feb. 14, 2001
By
James Etheridge
French Advancing Legislation To Allow Therapeutic Cloning
Feb. 14, 2001
By
James Etheridge
Despite Resistance In France, Chirac Sees Place For GM Crops
Feb. 14, 2001
By
James Etheridge
View All Articles by James Etheridge
